Angioarrestin mRNA expression in early-stage lung cancers

European Journal of Surgical Oncology

Volumn 29, Issue 8, 2003, Pages 649-653

  Sasaki, Hidefumi ^a   Moriyama, S ^a   Sekimura, A ^a   Mizuno, K ^a   Yukiue, H ^a   Konishi, A ^a   Yano, M ^a   Kaji, M ^a   Fukai, I ^a   Yamakawa, Y ^a   Fujii, Y ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Angioarrestin; Angiogenesis; Lung cancer; Tumorigenesis

Indexed keywords

ANGIOARRESTIN; ANGIOGENESIS INHIBITOR; ANGIOPOIETIN; MESSENGER RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CLINICAL FEATURE; CONTROLLED STUDY; DEVICE; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE ISOLATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; STATISTICAL ANALYSIS;

EID: 0141885994     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0748-7983(03)00106-9     Document Type: Article

References (29)

1. Ministry of Health and Welfare, Statistics and Information Department, Vital Statistics, 1994, Vol. 3, 1996; 96-108.
2. Ginsberg RJ, Kris MK, Armstrong JG. Cancer of the lung. Principles and Practice of Oncology, 4th edn. Philadelphia: Lippincott, 1993: 673-82.
3. Yasuda K, Ayabe H, Ide H, on behalf of the Japanese Association for Thoracic Surgery Thoracic and cardiovascular surgery in Japan during 1998 et al. Annual report by the Japanese association for thoracic surgery. Jpn J Thorac Vasc Surg 1998; 48: 401-15.
4. Mountain CF. Revisions in the international system for staging lung cancer. Chest 1997; 111: 1710-7.
5. In: Kazikoe T (ed.), Cancer Statistics in Japan 1997. Tokyo, Japan: Foundation for Promotion of Cancer Research, 1997.
6. Strauss GM, et al. Bronchogenic carcinoma. In: Baum GL, Crapo JD, Celli BR, et al. (eds), 6th edn. Textbook of Pulmonary Disease, Vol. 6. Philadelphia, PA: Lippincott-Raven, 1998: 1329-81.
7. Hart IR, Saini A. Biology of tumor metastasis. Lancet 1992; 339: 1453-7.
8. Folkman J. Tumor angiogenesis. Adv Cancer Res 1974; 19: 331-58.
9. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
10. Kim I, Kwak HJ, Ahn JE, So JN, Liu M, Koh KN et al. Molecular cloning and characterization of a novel angiopoietin family protein, angiopoietin-3. FEBS Lett 1999; 443: 353-6.
11. Kim I, Moon SO, Koh KN, Kim H, Uhm CS, Kwak HJ et al. Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting. J Biol Chem 1999; 274: 26523-8.
12. Dhanabal M, LaRochelle WJ, Jeffers M, Herrmann J, Rastelli L, McDonald WF et al. Angioarrestin: an antiangiogenic protein with tumor-inhibition properties. Cancer Res 2002; 62: 3834-41.
13. Wong MP, Chan SY, Fu KH, Leung SY, Cheung N, Yuen ST et al. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas. Lung Cancer 2000; 29: 11-22.
14. Japan Lung Cancer Society, General Rule for Clinical and Pathological Record of Lung Cancer, 5th edn, 1999: 1-177.
15. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990; 82: 4-6.
16. Folkman J. Angiogemnesis in cancer, vascular, rheumatoid and other disease. Nature Med 1995; 1: 27-31.
17. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature (Lond.) 1989; 339: 58-61.
18. Hanahan D. Signaling vascular morphogenesis and maintenance. Science (Washington DC) 1997; 277: 48-50.
19. Folkman J, D' Amore PA. Blood vessel formation: what is its molecule basis? Cell 1996; 87: 1153-5.
20. Klagsbrun M, D' Amore PA. A regulation of angiogenesis. Annu Rev Physiol 1991; 53: 217-39.
21. Folkman J. Tumor angiogenesis. In: Mendelsohn J, Howley P, Liotta LA, Israel M (eds) The Molecular Basis of Cancer. Philadelphia: W. B. Saunders, 1995: 206-32.
22. Craft PS, Harris AL. Clinical prognostic significance of tumor angiogenesis. Ann Oncol 1994; 5: 305-11.
23. Nicolson GL. Breast cancer metastasis-associated gene: role in tumor progression to the metastatic state. Biochem Soc Symp 1998; 63: 231-43.
24. August DA, Sugarbaker PH, Schneider PD. Lymphatic dissemination of hepatic metastases. Implications for the follow-up and treatment of patients with colorectal cancer. Cancer (Phila.) 1985; 55: 1490-4.
25. Di Gianni P, Franco M, Meiss RP, Vanzull S, Piazzon I, Pasqualini CD et al. Inhibition of metastases by a serum factor associated to concomitant resistance induced by unrelated murine tumors. Oncol Rep 1999; 6: 1073-84.
26. O'Reilly MS, Rosenthal R, Sage EH, Smith S, Holmgren L, Mose M et al. The suppression of tumor metastases by primary tumor. Surg Forum (Chic) 1993; 44: 474-6.
27. Chen C, Parangi S, Tolentino MJ, Folkman J. A strategy to discover circulation angiogenesis inhibitors generated by human tumors. Cancer Res 1995; 55: 4230-3.
28. Suzuki M, Iizasa T, Ko E, Baba M, Saito Y, Shibuya K et al. Serum endostatin correlates with progression and prognosis of non-small cell lung cancer. Lung Cancer 2002; 35: 29-34.
29. Deslauriers J, Gregoire J. Clinical and staging of non-small cell lung cancer. Chest 2000; 117: 96-103.